Payment overview · 2025
General Payments
$207.29
11 reported records · 9 companies
Healthcare provider profile · identity verified
Jeffrey Scharstein, MD
Allopathic & Osteopathic Physicians|Family Medicine · DARLINGTON, SC · NPI 1588636161
Verified facts
What the public records show
CMS Open Payments records show Jeffrey Scharstein, MD received $207.29 in general payments during 2025 across 11 reported records.
Esperion Therapeutics, Inc. accounted for 18.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 10 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 113 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Lumigan by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Vraylar by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 331 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Esperion Therapeutics, Inc. | Unresolved — no canonical attribution shown | $38.85 | 18.7% | 2 | 2025 |
| Xeris Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $31.78 | 15.3% | 2 | 2025 |
| SCILEX PHARMACEUTICALS INC. | Unresolved — no canonical attribution shown | $25.05 | 12.1% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $22.45 | 10.8% | 1 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $20.46 | 9.9% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $20.33 | 9.8% | 1 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $18.27 | 8.8% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $17.03 | 8.2% | 1 | 2025 |
| CVRx, Inc. | Unresolved — no canonical attribution shown | $13.07 | 6.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $207.29 | 11 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NEXLETOL Normalized: nexletol |
Drug | Esperion Therapeutics, Inc. | $38.85 | 2 | 2025 |
Source payment records
|
|||||
| GVOKE HYPOPEN Normalized: gvoke hypopen |
Drug | Xeris Pharmaceuticals, Inc. | $31.78 | 2 | 2025 |
Source payment records
|
|||||
| ZTLido Normalized: ztlido |
Drug | SCILEX PHARMACEUTICALS INC. | $25.05 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $22.45 | 1 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $20.46 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $20.33 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $20.33 | 1 | 2025 |
Source payment records
|
|||||
| WATCHMAN FLX Normalized: watchman flx |
Device | Boston Scientific Corporation | $18.27 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $17.03 | 1 | 2025 |
Source payment records
|
|||||
| Barostim Neo System Normalized: barostim neo system |
Device | CVRx, Inc. | $13.07 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 331 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
113 | 22 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
37 | 11 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VRAYLAR open payments reported associated product |
CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550 |
Vraylar · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
331 | 54 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1235 | 269 |
| Amlodipine Besylate | Amlodipine Besylate | 938 | 217 |
| Alprazolam | Alprazolam | 816 | 121 |
| Levothyroxine Sodium | Levothyroxine Sodium | 727 | 122 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 661 | 93 |
| Gabapentin | Gabapentin | 592 | 121 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 543 | 141 |
| Pantoprazole Sodium | Pantoprazole Sodium | 539 | 124 |
| Metformin Hcl | Metformin Hcl | 517 | 126 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 510 | 103 |
| Furosemide | Furosemide | 480 | 110 |
| Omeprazole | Omeprazole | 415 | 101 |
| Eliquis | Apixaban | 411 | 54 |
| Potassium Chloride | Potassium Chloride | 402 | 99 |
| Metoprolol Succinate | Metoprolol Succinate | 400 | 103 |
| Metoprolol Tartrate | Metoprolol Tartrate | 371 | 72 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 352 | 93 |
| Tamsulosin Hcl | Tamsulosin Hcl | 341 | 74 |
| Ozempic | Semaglutide | 331 | 54 |
| Lisinopril | Lisinopril | 320 | 64 |
| Tramadol Hcl | Tramadol Hcl | 301 | 68 |
| Carvedilol | Carvedilol | 290 | 64 |
| Glipizide | Glipizide | 273 | 60 |
| Hydrochlorothiazide | Hydrochlorothiazide | 251 | 73 |
| Enalapril Maleate | Enalapril Maleate | 250 | 55 |
| Diclofenac Sodium | Diclofenac Sodium | 247 | 80 |
| Escitalopram Oxalate | Escitalopram Oxalate | 244 | 55 |
| Baclofen | Baclofen | 219 | 78 |
| Atenolol | Atenolol | 218 | 57 |
| Levetiracetam | Levetiracetam | 216 | 35 |
| Sertraline Hcl | Sertraline Hcl | 216 | 39 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 215 | 50 |
| Losartan Potassium | Losartan Potassium | 214 | 61 |
| Clopidogrel | Clopidogrel Bisulfate | 186 | 43 |
| Allopurinol | Allopurinol | 178 | 32 |
| Quetiapine Fumarate | Quetiapine Fumarate | 161 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 156 | 29 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 156 | 31 |
| Ibuprofen | Ibuprofen | 156 | 43 |
| Spironolactone | Spironolactone | 156 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 152 | 54 |
| Torsemide | Torsemide | 147 | 41 |
| Jardiance | Empagliflozin | 145 | 18 |
| Glipizide Er | Glipizide | 144 | 34 |
| Donepezil Hcl | Donepezil Hcl | 143 | 28 |
| Zolpidem Tartrate | Zolpidem Tartrate | 141 | 30 |
| Montelukast Sodium | Montelukast Sodium | 140 | 32 |
| Pregabalin | Pregabalin | 137 | 25 |
| Trazodone Hcl | Trazodone Hcl | 135 | 27 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 134 | 27 |
| Nabumetone | Nabumetone | 134 | 47 |
| Hydralazine Hcl | Hydralazine Hcl | 133 | 36 |
| Ondansetron Hcl | Ondansetron Hcl | 133 | 53 |
| Lorazepam | Lorazepam | 132 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 130 | 31 |
| Famotidine | Famotidine | 129 | 25 |
| Mirtazapine | Mirtazapine | 123 | 25 |
| Naproxen | Naproxen | 123 | 43 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 117 | 53 |
| Azithromycin | Azithromycin | 115 | 81 |
| Linzess | Linaclotide | 113 | 22 |
| Amitriptyline Hcl | Amitriptyline Hcl | 111 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 111 | 23 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 110 | 24 |
| Metformin Hcl Er | Metformin Hcl | 108 | 33 |
| Paroxetine Hcl | Paroxetine Hcl | 107 | 17 |
| Nifedipine Er | Nifedipine | 106 | 25 |
| Warfarin Sodium | Warfarin Sodium | 106 | 18 |
| Doxycycline Hyclate | Doxycycline Hyclate | 105 | 71 |
| Simvastatin | Simvastatin | 102 | 20 |
| Valsartan | Valsartan | 102 | 22 |
| Benazepril Hcl | Benazepril Hcl | 98 | 24 |
| Methylprednisolone | Methylprednisolone | 94 | 77 |
| Cefdinir | Cefdinir | 89 | 77 |
| Citalopram Hbr | Citalopram Hydrobromide | 89 | 14 |
| Prednisone | Prednisone | 85 | 35 |
| Clonidine Hcl | Clonidine Hcl | 83 | 23 |
| Mounjaro | Tirzepatide | 83 | 11 |
| Temazepam | Temazepam | 82 | 15 |
| Terbinafine Hcl | Terbinafine Hcl | 82 | 26 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 78 | 16 |
| Fenofibrate | Fenofibrate | 76 | 15 |
| Xarelto | Rivaroxaban | 75 | 11 |
| Levofloxacin | Levofloxacin | 74 | 66 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 73 | 14 |
| Diazepam | Diazepam | 71 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 71 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 70 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 67 | 12 |
| Sucralfate | Sucralfate | 67 | suppressed |
| Fluconazole | Fluconazole | 66 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 66 | 14 |
| Nitroglycerin | Nitroglycerin | 66 | 27 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 66 | suppressed |
| Ezetimibe | Ezetimibe | 63 | 16 |
| Ondansetron Odt | Ondansetron | 63 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 62 | 45 |
| Divalproex Sodium | Divalproex Sodium | 62 | 11 |
| Finasteride | Finasteride | 62 | 12 |
| Colchicine | Colchicine | 61 | 27 |
| Sevelamer Carbonate | Sevelamer Carbonate | 61 | suppressed |
| Latanoprost | Latanoprost | 60 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 59 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 59 | 12 |
| Meloxicam | Meloxicam | 59 | 14 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 59 | 25 |
| Doxazosin Mesylate | Doxazosin Mesylate | 58 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 57 | 15 |
| Humalog Kwikpen U-100 | Insulin Lispro | 57 | 15 |
| Alendronate Sodium | Alendronate Sodium | 56 | 13 |
| Clobetasol Propionate | Clobetasol Propionate | 56 | 31 |
| Entresto | Sacubitril/Valsartan | 56 | suppressed |
| Lacosamide | Lacosamide | 56 | suppressed |
| Memantine Hcl | Memantine Hcl | 56 | suppressed |
| Lansoprazole | Lansoprazole | 54 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 53 | 21 |
| Promethazine Hcl | Promethazine Hcl | 53 | 17 |
| Pioglitazone Hcl | Pioglitazone Hcl | 52 | 14 |
| Fenofibrate | Fenofibrate Nanocrystallized | 51 | 11 |
| Januvia | Sitagliptin Phosphate | 51 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 51 | 25 |
| Cephalexin | Cephalexin | 50 | 39 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 50 | 21 |
| Buspirone Hcl | Buspirone Hcl | 49 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 49 | suppressed |
| Clonazepam | Clonazepam | 44 | suppressed |
| Estradiol | Estradiol | 43 | suppressed |
| Methotrexate | Methotrexate Sodium | 43 | suppressed |
| Sotalol | Sotalol Hcl | 42 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 41 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 40 | 14 |
| Oxycodone Hcl | Oxycodone Hcl | 40 | 16 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 39 | 13 |
| Risperidone | Risperidone | 38 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 38 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 37 | suppressed |
| Ranolazine Er | Ranolazine | 37 | suppressed |
| Synthroid | Levothyroxine Sodium | 37 | 11 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 36 | 12 |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 36 | 14 |
| Tresiba Flextouch U-200 | Insulin Degludec | 36 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 35 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 33 | suppressed |
| Lactulose | Lactulose | 33 | suppressed |
| Letrozole | Letrozole | 33 | suppressed |
| Cilostazol | Cilostazol | 32 | suppressed |
| Tradjenta | Linagliptin | 32 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 31 | suppressed |
| Sulindac | Sulindac | 31 | 12 |
| Aripiprazole | Aripiprazole | 30 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 30 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 30 | suppressed |
| Lidocaine | Lidocaine | 30 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 30 | suppressed |
| Trulicity | Dulaglutide | 30 | suppressed |
| Levemir Flexpen | Insulin Detemir | 29 | 11 |
| Novolog Flexpen | Insulin Aspart | 29 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | 11 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 28 | suppressed |
| Topiramate | Topiramate | 28 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 27 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 27 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 26 | suppressed |
| Bumetanide | Bumetanide | 25 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 25 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 25 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 25 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 25 | suppressed |
| Carbamazepine | Carbamazepine | 24 | suppressed |
| Celecoxib | Celecoxib | 24 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 24 | 12 |
| Single Use Swab | Alcohol Antiseptic Pads | 24 | 11 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 23 | 16 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 23 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 22 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 22 | suppressed |
| Glimepiride | Glimepiride | 22 | suppressed |
| Klor-Con M20 | Potassium Chloride | 22 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 22 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 21 | suppressed |
| Gemfibrozil | Gemfibrozil | 21 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 21 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 21 | 11 |
| Rhopressa | Netarsudil Mesylate | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Amoxicillin | Amoxicillin | 20 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 17 |
| Clindamycin Hcl | Clindamycin Hcl | 20 | 19 |
| Divalproex Sodium Er | Divalproex Sodium | 20 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 20 | suppressed |
| Calcitriol | Calcitriol | 19 | suppressed |
| Ibu | Ibuprofen | 19 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 19 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 19 | suppressed |
| Irbesartan | Irbesartan | 18 | suppressed |
| Norvasc | Amlodipine Besylate | 18 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Humalog Kwikpen U-200 | Insulin Lispro | 17 | suppressed |
| Mupirocin | Mupirocin | 17 | 13 |
| Scopolamine | Scopolamine | 17 | suppressed |
| Bupropion Xl | Bupropion Hcl | 16 | suppressed |
| Dutasteride | Dutasteride | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Xanax | Alprazolam | 16 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 15 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 14 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 14 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 14 | suppressed |
| Nexium | Esomeprazole Magnesium | 14 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 14 | suppressed |
| Vraylar | Cariprazine Hcl | 14 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 13 | suppressed |
| Glyburide | Glyburide | 13 | suppressed |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 13 | suppressed |
| Indomethacin | Indomethacin | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 13 | suppressed |
| Movantik | Naloxegol Oxalate | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 13 | suppressed |
| Roflumilast | Roflumilast | 13 | suppressed |
| Ssd | Silver Sulfadiazine | 13 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 13 | suppressed |
| Alphagan P | Brimonidine Tartrate | 12 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 12 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 12 | suppressed |
| Fentanyl | Fentanyl | 12 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Hydroxyurea | Hydroxyurea | 12 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Carbamazepine Er | Carbamazepine | 11 | suppressed |
| Fluphenazine Decanoate | Fluphenazine Decanoate | 11 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 11 | suppressed |
| Lumigan | Bimatoprost | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Mirabegron Er | Mirabegron | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Zenpep | Lipase/Protease/Amylase | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $207.29 · 11 records | Esperion Therapeutics, Inc. | Auvelity, Barostim Neo System, Cologuard Collection Kit, GVOKE HYPOPEN, NEXLETOL, Ozempic, Rybelsus, UBRELVY, WATCHMAN FLX, ZTLido | 5 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error